VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
VECTDelisted Stock | USD 16.85 0.00 0.00% |
Slightly above 56% of VectivBio Holding's investor base is looking to short. The analysis of current outlook of investing in VectivBio Holding AG suggests that many traders are alarmed regarding VectivBio Holding's prospects. VectivBio Holding's investing sentiment can be driven by a variety of factors including economic data, VectivBio Holding's earnings reports, geopolitical events, and overall market trends.
VectivBio |
Management to Host Conference Call Wednesday, April 19, 2023, at 8.00 a.m. ETBASEL, Switzerland, April 12, 2023 -- VectivBio Holding AG , a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced they will report financial results for the full year ended December 31, 2022 and provide a business update on Wednesday, April 19, 2023 at 800 a.m. ET. A live webcast will be accessibl
Read at finance.yahoo.com
![]() |
VectivBio Holding Fundamental Analysis
We analyze VectivBio Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
VectivBio Holding is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
VectivBio Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VectivBio Holding stock to make a market-neutral strategy. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics with similar companies.
Peers
VectivBio Holding Related Equities
CNSP | Cns Pharmaceuticals | 10.00 | ||||
ZVSA | ZyVersa Therapeutics | 10.00 | ||||
HEPA | Hepion Pharmaceuticals | 7.69 | ||||
ZURA | Zura Bio | 0.80 | ||||
ELEV | Elevation Oncology | 5.97 | ||||
OCEA | Ocean Biomedical | 7.94 | ||||
IMMX | Immix Biopharma | 8.30 | ||||
ENVB | Enveric Biosciences | 10.81 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |